Fujifilm Diosynth Biotechnologies
Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Fujifilm selects North Carolina site for planned manufacturing facility
Fujifilm Diosynth Biotechnologies chose Holly Springs, North Carolina, as the site for its planned $2 billion cell-culture manufacturing facility. The company said the facility would add just under 1,000 jobs in the area by 2028.
2021
Fujifilm Diosynth announces North Carolina manufacturing facility plan
Fujifilm Diosynth Biotechnologies announced plans to build a drug manufacturing facility in Holly Springs, North Carolina, with a planned $2 billion investment and 725 jobs.
2021
Fujifilm Diosynth announces planned North Carolina drug manufacturing facility
Fujifilm Diosynth Biotechnologies announced plans to build a drug manufacturing facility in Holly Springs, North Carolina, with a stated investment of $2 billion and 725 jobs.
2020
FUJIFILM Diosynth Biotechnologies announces CEO succession
FUJIFILM Diosynth Biotechnologies announced that Martin Meeson had been appointed to succeed Steve Bagshaw as CEO. Bagshaw's retirement from the CEO position and Meeson's succession were stated to take effect on April 1, 2020; Bagshaw would continue as non-executive chairman.